dentalcorp (DNTL) Q4 2024 earnings summary

Executive summary

• Operates in a CAD 22 billion, highly fragmented Canadian dental market with only 7% consolidation, serving over 2.3 million active patients and completing 5.5 million visits in 2024 across 561 practices, up 2.9% year-over-year.

• Delivered strong financial and operational results for Q4 and fiscal 2024, meeting or exceeding expectations, with revenue up 8.4% to $1.55B and adjusted EBITDA up 9.8% to $285.2M.

• Recurring patient visits reached 91.6% in Q4 2024, with 2.3M active patients.

• Net loss for 2024 was ($59M), narrowing from ($86M) in 2023.

• Leverage ratio improved to 3.8x Net Debt/PF Adjusted EBITDA after rent, down from 4.4x.

Financial highlights

• Q4 2024 revenue was $397.5M, up 9.7% year-over-year; adjusted EBITDA was $73.9M, up 12.3%.

• Adjusted EBITDA margin reached 18.6% in Q4, the highest in nine quarters, and 18.5% for the year.

• Adjusted free cash flow for 2024 was $151.8M, up 19.3% year-over-year; Q4 adjusted free cash flow per share was $0.20, up 11.1%.

• Practice-level EBITDA after rent margin averaged 22%+; average revenue per practice was $2.9M.

• Ended Q4 2024 with liquidity of $432.5M, including cash and undrawn debt capacity.

Outlook and guidance

• Expects 2025 revenue growth of 10%-11% to $1.7B+, with same practice revenue growth of 3%-5%.

• Adjusted EBITDA margin projected to expand by 20 basis points to ~18.7%; pre-tax adjusted free cash flow per share targeted to grow 15%+.

• Q1 2025 revenue expected to increase 8%-9% year-over-year, with 3%-5% same practice revenue growth.

• Plans to complete acquisitions representing over $25M in pro forma adjusted EBITDA after rent in 2025, with 60% already signed or closed.

• Net Debt/PF Adjusted EBITDA after rent ratio targeted at 3.0x–3.5x medium-term.